Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03415425 · ClinicalTrials.gov registry record · NA
Optimizing the Influenza Clinical Decision Support Tool
A NA study, sponsored by NYU Langone Health.
- Completed
- Registry status
- NA
- Development phase
- 25,881
- Enrollment target
NCT03415425 is a NA study that has completed, run by NYU Langone Health. The registered enrollment target is 25,881 participants.
The verdict
NCT03415425, a NA study, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 25,881 participants
- Enrollment target
Study Summary
The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
Interventions
- OTHER Current Version of the Influenza Alert
- OTHER Alternate Modifications of the Influenza Alert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25,881 participants |
| Start Date | 2018-01-16 |
| Est. Completion | 2023-11-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03415425
The ClinicalTrials.gov registry entry for NCT03415425 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 25,881 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Current Version of the Influenza Alert is the first listed.
NCT03415425 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03415425 about?
NCT03415425 is a clinical study titled "Optimizing the Influenza Clinical Decision Support Tool". The proposed study aims to examine several iterations of the Influenza Best Practice Alert at NYU Langone Health. The goal is to increase ordering of the influenza vaccine through the alert.
What is the current status of trial NCT03415425?
This trial is currently completed. It is a NA study. The enrollment target is 25,881 participants. The study started on 2018-01-16. Estimated completion is 2023-11-21.
What interventions are being tested in trial NCT03415425?
The interventions under investigation include: Current Version of the Influenza Alert (OTHER), Alternate Modifications of the Influenza Alert (OTHER).
Who is sponsoring clinical trial NCT03415425?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.